Dätwyler (DAE) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
31 Oct, 2026Executive summary
FY23 revenue was CHF 1,151.5m, essentially flat YoY; organic revenue declined 0.3% after adjusting for acquisitions and currency effects.
Lost Covid sales, customer destocking and negative FX pressured performance; the 10.9% H2 EBIT margin indicated recovery from the first-half trough.
Financial highlights
EBIT was CHF 120.4m vs CHF 149.2m; EBIT margin was 10.5% vs 13.0%.
Net result was CHF 66.8m vs CHF 104.8m; EPS was CHF 3.93 vs CHF 6.16.
Net finance costs rose to CHF 28.7m from CHF 12.3m, driven by CHF 14.6m in acquisition-financing interest and CHF 14.2m from adverse FX movements.
Outlook and guidance
FY24 revenue growth guided in the low single-digit range at comparable exchange rates, with an improved EBIT margin.
Margin drivers include lower energy costs, optimized cost structures, recovery in Connectors and utilization-related scaling effects.
Mid-term goals are revenue growth of 6%–10% and an EBIT margin of 18%–21%.
Latest events from Dätwyler
- Revenue and margins rose, led by Healthcare and Capsul'in, with transformation progress and positive outlook.DAE
H1 2026 - EBIT margin rose to 12.4% as Healthcare-led growth drove strong results and outlook.DAE
H2 2025 - Transformation and innovation target 17%+ EBIT margin and growth in high-value markets.DAE
CMD 2025 - EBIT margin rose to 12.2% as Healthcare and F&B drove growth amid FX and industry headwinds.DAE
H1 2025 - EBIT margin rose to 11.8% as profits grew despite a 5% revenue drop and weak healthcare demand.DAE
H1 2024 - Profitability held steady as revenue fell 3.8% and transformation program targeted future gains.DAE
H2 2024